ATC Group: R03DC53 Montelukast, combinations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03DC53 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03D Other systemic drugs for obstructive airway diseases
4 R03DC Leukotriene receptor antagonists
5 R03DC53

Medicines in this ATC group

Brazil (BR)

Ecuador (EC)

Nigeria (NG)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.